Adam Daniel Cutler
Net worth: 385 621 $ as of 2024-03-30
Profile
Mr. Adam D.
Cutler is a Chief Financial & Accounting Officer at Mural Oncology Plc.
Mr. Cutler was previously employed as a Chief Financial Officer by Q32 Bio, Inc. (Massachusetts), an Independent Director by Navidea Biopharmaceuticals, Inc., a Chief Financial Officer, Secretary & Treasurer by Molecular Templates, Inc., an Independent Director by InMed Pharmaceuticals, Inc., a Senior Vice President-Corporate Affairs by Arbutus Biopharma Corp., a Managing Director by The Trout Group LLC, a Managing Director by Trout Capital LLC, a Managing Director by Canaccord Genuity, Inc., an Associate Analyst by Banc of America Securities LLC, a Research Analyst by Credit Suisse Securities (USA) LLC (Broker), an Analyst by The Frankel Group Associates LLC, and a Consultant by Ernst & Young LLP.
He also served on the board at JMP Securities LLC.
He received his undergraduate degree from Brandeis University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
0.47% | 2023-12-13 | 78,859 ( 0.47% ) | 385 621 $ | 2024-03-30 |
Adam Daniel Cutler active positions
Companies | Position | Start |
---|
Former positions of Adam Daniel Cutler
Companies | Position | End |
---|---|---|
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Director of Finance/CFO | 2023-09-30 |
INMED PHARMACEUTICALS INC. | Director/Board Member | 2022-08-07 |
MOLECULAR TEMPLATES, INC. | Director of Finance/CFO | 2021-07-01 |
NAVIDEA BIOPHARMACEUTICALS, INC. | Director/Board Member | 2021-05-03 |
ARBUTUS BIOPHARMA CORPORATION | Corporate Officer/Principal | 2017-10-31 |
Training of Adam Daniel Cutler
Brandeis University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
NAVIDEA BIOPHARMACEUTICALS, INC. | Health Technology |
ARBUTUS BIOPHARMA CORPORATION | Health Technology |
INMED PHARMACEUTICALS INC. | Health Technology |
MOLECULAR TEMPLATES, INC. | Health Technology |
Private companies | 6 |
---|---|
Credit Suisse Securities (USA) LLC (Broker)
Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Finance |
JMP Securities LLC
JMP Securities LLC Investment Banks/BrokersFinance Citizens JMP Securities LLC (Citizens JMP) is a full-service investment bank and broker/dealer headquartered in San Francisco, California. The firm was founded by Joseph Jolson in 2002 and was formerly JMP Securities LLC. The firm is a subsidiary of JMP Holding LLC, ultimately held by Citizens Financial Group, Inc. (NYSE: CFG). Citizens JMP provides equity research, institutional brokerage, and investment banking services to public and private growth companies and their investors. They are a research-driven, growth-oriented firm that provides services to small- and mid-sized companies and the institutions that invest in them. The firm specializes in four high-growth sectors of the economy: technology, healthcare, financial services, and real estate. | Finance |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Banc of America Securities LLC
Banc of America Securities LLC Investment Banks/BrokersFinance Headquartered in Charlotte, North Carolina, Banc of America Securities (BAS) is the investment banking subsidiary of Bank of America Corp (NYSE: BAC). The firm provides both the domestic and international equity and investment banking markets, and pursues a strategy pioneered by Citigroup that combines corporate lending with investment banking advice and services. They provide high-yield debt underwriting and leveraged finance, in addition to industry coverage groups such as healthcare, media and telecom, financial institutions, real estate and gaming. BAS also does a significant amount of work for Financial Sponsors, or private equity firms, often financing leveraged transactions. Following the strategy of Goldman Sachs, the firm lacks a standalone mergers and acquisitions department, instead employing mergers and acquisitions senior bankers throughout the industry coverage groups. The firm is registered as a broker/dealer with the SEC, is a member of the NYSE, and the NASD. The use of Banc in the BAS's name is indicative of the fact that the company is not a bank, and their deposits and other holdings are not insured by the FDIC. | Finance |
Canaccord Genuity, Inc.
Canaccord Genuity, Inc. Investment Banks/BrokersFinance Founded in 2006, Canaccord Genuity, Inc. is a registered broker/dealer headquartered in New York City. The firm is the U.S. arm of Toronto-based Canaccord Genuity Corp., the global capital markets division of Canaccord Financial, Inc. (CF: TSX / CF: AIM). Canaccord Genuity's research focuses on the following sectors of the global economy: metals/mining, energy, agriculture, technology, telecommunications, financials, consumer products, real estate, transportation, infrastructure, sustainability, life sciences, support services and investment trusts. Canaccord Genuity, Inc. is a member of FINRA/SIPC. | Finance |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Adam Daniel Cutler